about
Mechanisms predisposing penile fracture and long-term outcomes on erectile and voiding functionsVariations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy: an open questionPsychotherapy: a missing piece in the puzzle of post radical prostatectomy erectile dysfunction rehabilitation.Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor TransrepressionTranscription factors involved in prostate gland adaptation to androgen deprivation.Prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial.Delivery of a urology online course using Moodle versus didactic lectures methods.Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.Unraveling Brazilian Indian population prostate good health: clinical, anthropometric and genetic features.Are we following the guidelines on non-muscle invasive bladder cancer?Safety and feasibility of radiofrequency ablation for treatment of Bosniak IV renal cystsChallenges on percutaneous nephrolithotomy in pregnancy: Supine position approach through ultrasound guidanceDigital rectal examination standardization for inexperienced hands: teaching medical students.Experimental animal model and RNA interference: a promising association for bladder cancer research.Diethylstilbestrol 1 mg in the Treatment of Acute Urinary Retention due to Prostatic Obstruction in the Elderly: A Preliminary Study.Is metabolic syndrome truly a risk factor for male lower urinary tract symptoms or just an epiphenomenon?Androgen receptor activity modulates responses to cisplatin treatment in bladder cancerMicroRNAs: a new paradigm on molecular urological oncology.Male fertility, obesity, and bariatric surgery.The interpretation of the figure of the prophet Jonah by Michelangelo on the ceiling of the Sistine Chapel: anatomical urological vision.Obesity and male infertility: a practical approach.Update in the classification and treatment of complex renal injuries.Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE").Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.The Mind: Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind?Transanal Minimally Invasive Surgery (TAMIS) to Treat Vesicorectal Fistula: A New Approach.Oral vaccine (OM-89) in the recurrent urinary tract infection prophylaxis: a realistic systematic review with meta-analysis.Schooling impacts on the overactive bladder diagnosis in women.Is there room for luminal-basal urothelial cell population quantification?Editorial Comment to Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer.Is there room for behavioral and modifiable health-related targets in the lower urinary tract symptoms' scenario.Intravesical bacillus Calmette-Guérin efficiently reduces p70S6K1 but not 4E-BP1 phosphorylation in nonmuscle invasive bladder cancer.Impact of benign prostatic hyperplasia pharmacological treatment on transrectal prostate biopsy adverse effects.Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.Barriers to prostate cancer screening: psychological aspects and descriptive variables---is there a correlation?Assessment of serum chromogranin-A as prognostic factor in high-risk prostate cancer.Evolution on experimental animal model for upper urothelium carcinogenesis.Female urethral carcinoma: evidences to origin from Skene's glands.Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
P50
Q21284657-23CC69EB-8802-430F-9D32-E6EC02690088Q27007155-C7B788D4-CC66-4FCB-A4F2-FCA52476B666Q33357406-BAC66936-C23C-41D6-8DDF-AB93F5E7C500Q33631526-30C3AF57-9EBF-4043-B827-A57C7D618249Q33699091-5ABB510C-6D2B-4F7B-BA3A-59024C5FBA08Q34093857-7F44D7F5-8E69-4DCD-A32A-2679D5C21DCEQ35481251-23119682-DB75-459B-9651-3313D577DA7BQ35866471-3EAA9E8E-7E37-4859-ACB5-EC7D1B530918Q36575833-AFB34EDE-938D-4A7E-A468-59705606B4C2Q36738114-68C443EE-A32C-41FF-8DF3-90C7F8FEDD71Q37037035-8E82C516-D85F-4629-B19A-D1503980EE53Q37151232-0660CDD6-42FF-4821-989A-9B6C28F91A7EQ37220260-234ACE84-DA17-4D74-AFE4-E7DC28529F8AQ37392045-569BE975-EB3A-4E5A-AC0D-C33C8824EE83Q37561207-D6BACAB3-FB52-4719-AF5C-6176332AD4CFQ37577512-A51F7C59-59EB-4FB1-85DA-472F5FFDFECEQ37580192-D4BBA397-5450-49FC-AC1A-FFB52AFA9669Q37753387-79864644-8D01-427B-A185-9DEE828C2B62Q38005533-2ADF72BB-E359-496C-95C8-81C5DD7C18B8Q38024165-18ECC59E-5E8A-4A2C-88DD-8862282E7F55Q38052867-65C59CEA-EBD3-49DC-8723-14EB71F3CE29Q38156659-60DEB739-C536-41D5-8A9A-F34D1E5BAFECQ38193586-C4248C20-DD3E-42F0-8AC8-18871689AD16Q38383771-B16E431B-B141-4CF8-A23B-8AEED90FBCF7Q38391339-2A7E4B55-75D2-46E9-83D5-476A5A0D2CD7Q38532712-AA1F46F4-65BB-4512-AA32-137336642571Q38646003-7D066970-CF0B-45B6-A022-DAABDF7507D8Q38670317-53AAB8C1-9877-4F3A-B092-95DDF295D72EQ38692176-99D1F47B-2766-4261-8042-5899E6C30109Q38736621-2E0C4E5D-249C-4716-9E8D-1257B9B46F21Q38739860-A16636C9-34F0-4E26-ABB0-4ACCF024E454Q38765727-120B27E9-2C06-4BD7-918D-CC176A0A2D3CQ39132629-75CE084C-E423-4231-9045-7BF46224C07AQ39184221-CCAF8532-50A9-4465-990A-BC86C86A6350Q39665461-ECFFEC7A-4828-4D23-A022-1CAD69C4E3E9Q39828964-2E6FD171-F716-4F99-95A9-EA7D24C52F2AQ39840762-1C20E3EE-A2BA-4538-B4A7-173310DB203EQ39885213-C09E75BB-3DCC-49F6-9910-CC54A7366A9DQ39978650-0067D683-8FA8-48BF-B6BE-78576C12ED2CQ40056522-F6F11D67-1A99-4011-908A-960719EEFAE9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Leonardo Oliveira Reis
@ast
Leonardo Oliveira Reis
@en
Leonardo Oliveira Reis
@es
Leonardo Oliveira Reis
@nl
Leonardo Oliveira Reis
@sl
type
label
Leonardo Oliveira Reis
@ast
Leonardo Oliveira Reis
@en
Leonardo Oliveira Reis
@es
Leonardo Oliveira Reis
@nl
Leonardo Oliveira Reis
@sl
altLabel
Oliveira Reis L
@en
prefLabel
Leonardo Oliveira Reis
@ast
Leonardo Oliveira Reis
@en
Leonardo Oliveira Reis
@es
Leonardo Oliveira Reis
@nl
Leonardo Oliveira Reis
@sl
P1053
B-3652-2011
P106
P1153
22836268400
P21
P2798
P31
P3829
P3835
leonardo-reis9
P496
0000-0003-2092-414X